Bioquell Share Discussion Threads

[scotswhaehae] 26/3/2007 08:01

Fantastic resuts and great vindication for the bulls...
These should rocket on the upgradings/reratings and positive vibes...
Just watch once the 'numbercrunchers' have done their stuff!

Good luck all!

[zipstuck] 26/3/2007 07:47

Difficult to predict this year profit with so much going on so valuation can only be on revenues and not p/e

[zipstuck] 26/3/2007 07:39

Except for the UD $

[wywcu1] 26/3/2007 07:29

Great results, get onboard, train now leaving the station.

[tp100] 08/3/2007 11:21

Piled in again this morning. Price action is promising.

[scotswhaehae] 08/3/2007 11:13

Starting its rise again...great stuff!

[scotswhaehae] 08/2/2007 11:11

The 15000 late trade was a buy if you check last night's close/this morning's progress...chunky for BQE!

[ckafetz] 23/1/2007 19:36

At least we may be presented with another good buying opportunity

[scotswhaehae] 23/1/2007 08:55

You may be right ckafetz...

We never quite got breakout...

Downside to 110p area at worst I would expect...

[ckafetz] 11/1/2007 23:44

why do you think a breakout will happen? is it not high enough already?

[scotswhaehae] 11/1/2007 15:47

Breakout...if we close here or higher!

Nice steady buying...

[scotswhaehae] 09/1/2007 16:16

Almost at breakout...

[scotswhaehae] 04/1/2007 12:09

...through 128p and we could fly...

good luck all!

[wes1] 28/12/2006 09:40

In the last month there has been 3 deaths at the City Hospital, Nottingham and 9 deaths at Queens Medical Centre, Nottingham - all linked to C.difficile.

[scotswhaehae] 28/12/2006 08:18

...lol...I wondered when someone would spot that!!

Hold on for a great ride imho...

[wes1] 27/12/2006 18:51

ulcer trials will be positive I suspect

[scotswhaehae] 27/12/2006 08:26

ho, ho, ho

very quiet here!

this looks like someone 'knows' we have good trading and is acquiring what he can!

good tidings all!

[scotswhaehae] 22/12/2006 12:00

Nice quiet (informed?!) buying continues...

Great stuff!


O/T another nap share of mine, GETM, is starting its rise too!


Merry Christmas all!

[scotswhaehae] 21/12/2006 11:14

Maybe we are going to get a (highly bullish) pre close seaon RNS...they produced what was effectively one this time last year...

Makes you think!

[wes1] 21/12/2006 11:09

RBDS has been used in over 50 hospitals worldwide

c. difficile is a big, big problem in Canada

[scotswhaehae] 21/12/2006 10:14

I think we are going to get a sneaky rally when no-one is looking...lol

Great stuff!

[turkey3] 12/12/2006 12:20

scotswhaehae ,

Saw your link on ast, used 2 trade this stock, so i've bought 3750 shares off wins, will buy more if i see any strenght.

[scotswhaehae] 12/12/2006 11:51

RNS shows Muir has added nearly 400000 shares to his earlier 3.6% holding...!!

Suggests somebody in the know likes what they hear!

Good luck all!

[scotswhaehae] 12/12/2006 08:30

Second leg up underway imho...someone seems to be hoovering up shares as they appear...

[wes1] 07/12/2006 08:51

It's not only superbugs that Bioquell is interested in - they are also into ulcers.

In September, they merely said "The development of the wound healing technology remains on track and the potential size of this market is substantial"

whereas in April of this year they said -

The Group has been carrying out innovative research and development into novel wound healing technology for over five years using its expertise in applying peroxide-based technology.

The wound healing market is large with, for example, one estimate suggesting that 4.5 million Americans per year suffer from chronic wounds with an estimated cost of $9.5 billion.

Appropriate patent applications have been made in a number of jurisdictions and patent examination is underway.

Clinical trials started last year on venous leg ulcers at the Wound Healing Research Unit, part of the University of Wales College of Medicine in Cardiff and one of the UK's leading centres for wound healing research.

Venous leg ulcers are generally recognised to be one of the hardest chronic wounds to heal and as a result BIOQUELL has been focussing its trials on such wounds.

We also intend to carry out research into other problematic chronic wounds such as diabetic foot ulcers.

The results of these trials are encouraging and should be made public by the academic team leading the trials later this year.

The necessary research, development and engineering required to bring a high quality medical device to market is substantially advanced.

We anticipate being in a position to launch the product on the UK market at the end of this year.

Work has started in relation to the information needed to satisfy the US and other overseas regulators, although at the current time it is difficult to forecast the timing of any international regulatory approvals.